GHDX

Genomic Health, Inc. News Headlines

$36.63
*  
0.56
1.55%
Get GHDX Alerts
*Delayed - data as of Oct. 31, 2014 9:30 ET  -  Find a broker to begin trading GHDX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GHDX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Only 2 High-Growth Healthcare Stocks Are Being Bought Up By Insiders
11/2/2012 4:55:00 AM - Seeking Alpha


Earnings Analysis: Quest Diagnostics Inc.
10/18/2012 5:32:00 PM - Seeking Alpha


Genomic Health: A Strong Buy - Analyst Blog
10/10/2012 12:30:01 PM - Zacks.com


Qiagen: Downside Priced In, CDx And Automation Upside, Undervalued Compared To Peers
9/29/2012 4:09:00 AM - Seeking Alpha


5 Highly Shorted Small-Caps With Strong Insider And Institutional Buying
9/18/2012 2:26:00 PM - Seeking Alpha


Genomic Health, Inc. Enters Oversold Territory - Tale of the Tape
9/12/2012 11:19:01 AM - Zacks.com


Cepheid Remains Neutral - Analyst Blog
8/22/2012 2:32:51 PM - Zacks.com


Agilent Wins Patent in US - Analyst Blog
8/21/2012 3:33:39 PM - Zacks.com


Genomic Health Back to Neutral - Analyst Blog
8/20/2012 7:22:01 PM - Zacks.com


Genomic Health Targets Middle East - Analyst Blog
8/14/2012 4:15:01 PM - Zacks.com


Genomic Health Beats on EPS - Analyst Blog
8/9/2012 10:15:01 AM - Zacks.com


CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares
7/13/2012 12:46:30 PM - GuruFocus


Genomic Health to Outperform - Analyst Blog
7/6/2012 3:30:01 PM - Zacks.com


Cepheid Expands European Portfolio - Analyst Blog
5/29/2012 3:30:01 PM - Zacks.com


FDA Nod for Cepheid's Infinity-80 - Analyst Blog
5/25/2012 10:44:31 AM - Zacks.com


Myriad in Research Partnership - Analyst Blog
5/22/2012 3:30:01 PM - Zacks.com


Genomic Health Stays Neutral - Analyst Blog
5/21/2012 3:39:05 PM - Zacks.com


Myriad Reiterated Neutral - Analyst Blog
5/18/2012 2:40:41 PM - Zacks.com


Cepheid Back to Neutral - Analyst Blog
5/14/2012 3:06:48 PM - Zacks.com


Will Mayo v. Prometheus Fire Up Pharma?: Kevin DeGeeter
5/10/2012 5:42:02 PM - International Business Times


Genomic Health Beats Estimates - Analyst Blog
5/3/2012 12:49:17 PM - Zacks.com


Myriad Beats, Raises Guidance - Analyst Blog
5/2/2012 3:45:01 PM - Zacks.com


Insiders are Spending MILLIONS on These 4 Small-Cap Stocks
4/10/2012 11:30:00 AM - Andy Obermueller


Cepheid Upgraded to Outperform - Analyst Blog
4/9/2012 3:30:01 PM - Zacks.com


Positive Data from Genomic Health - Analyst Blog
3/22/2012 3:21:50 PM - Zacks.com